17 research outputs found
Forest plot displaying the pooled summary estimates of BCVA in the study group versus the control group: A at 1 month, B at 6 months, and C at 12 months.
<p>BCVA =  best-corrected visual acuity; IVTA =  intravitreal injection of triamcinolone acetonide; MPC =  macular photocoagulation; PRP =  pan-retinal photocoagulation; SD =  standard deviation; IV =  weighted mean difference; CI =  confidence interval; df =  degrees of freedom; Chi<sup>2</sup> =  chi-square statistic; p =  p value; I<sup>2</sup> =  I-square heterogeneity statistic; Z =  Z statistic.</p
Flow chart demonstrating the process for study inclusion in the meta-analysis.
<p>Flow chart demonstrating the process for study inclusion in the meta-analysis.</p
Characteristics of randomized controlled trials (RCTs) evaluating IVTA combined with PRP and MPC for treating PDR and DME.
<p>IVTA =  intravitreal injection of triamcinolone acetonide; PRP =  panretinal photocoagulation; BCVA =  best corrected visual acuity; FA =  fluorescein angiography; CMT =  central macular thickness; NA =  not available; RAFL =  perimetric area of fluorescein leakage; SMCT =  standardized changes in macular thickness; MPC =  macular photocoagulation; TMV =  total macular volume; IOP =  intraocular pressure.</p>*<p>any change in VA compared with the pre-injection level.</p
Forest plot displaying the pooled summary estimates of IOP in the study group versus control group at 6 months.
<p>IOP =  intraocular pressure; IVTA =  intravitreal injection of triamcinolone acetonide; MPC =  macular photocoagulation; PRP =  pan-retinal photocoagulation; SD =  standard deviation; IV =  weighted mean difference; CI =  confidence interval; df =  degrees of freedom; Chi<sup>2</sup> =  chi-square statistic; p =  p value; I<sup>2</sup> =  I-square heterogeneity statistic; Z =  Z statistic.</p
Funnel plot of randomized controlled trials(A).
<p>Risk of bias summary across all studies; ‘+’: present; ‘−’: absent; ‘?’: questionable(B).</p
Forest plot displaying the pooled summary estimates of CMT in the study group versus the control group: A at 1 month, B at 3 months, C at 6 months, and D at 12 months.
<p>CMT =  central macular thickness; IVTA =  intravitreal injection of triamcinolone acetonide; MPC =  macular photocoagulation; PRP =  pan-retinal photocoagulation; SD = standard deviation; IV =  weighted mean difference; CI =  confidence interval; df =  degrees of freedom; Chi<sup>2</sup> =  chi-square statistic; p =  p value; I<sup>2</sup> =  I-square heterogeneity statistic; Z =  Z statistic.</p
Stable, Temperature-Dependent Gas Mixture Permeation and Separation through Suspended Nanoporous Single-Layer Graphene Membranes
Graphene membranes with nanometer-scale
pores could exhibit an
extremely high permeance and selectivity for the separation of gas
mixtures. However, to date, no experimental measurements of gas mixture
separation through nanoporous single-layer graphene (SLG) membranes
have been reported. Herein, we report the first measurements of the
temperature-dependent permeance of gas mixtures in an equimolar mixture
feed containing H<sub>2</sub>, He, CH<sub>4</sub>, CO<sub>2</sub>,
and SF<sub>6</sub> from 22 to 208 °C through SLG membranes containing
nanopores formed spontaneously during graphene synthesis. Five membranes
were fabricated by transfer of CVD graphene from catalytic Cu film
onto channels framed in impermeable Ni. Two membranes exhibited gas
permeances on the order of 10<sup>–6</sup> to 10<sup>–5</sup> mol m<sup>–2</sup> s<sup>–1</sup> Pa<sup>–1</sup> as well as gas mixture selectivities higher than the Knudsen effusion
selectivities predicted by the gas effusion mechanism. We show that
a new steric selectivity mechanism explains the permeance data and
selectivities. This mechanism predicts a mean pore diameter of 2.5
nm and an areal pore density of 7.3 × 10<sup>13</sup> m<sup>–2</sup>, which is validated by experimental observations. A third membrane
exhibited selectivities lower than the Knudsen effusion selectivities,
suggesting a combination of effusion and viscous flow. A fourth membrane
exhibited increasing permeance values as functions of temperature
from 27 to 200 °C, and a CO<sub>2</sub>/SF<sub>6</sub> selectivity
> 20 at 200 °C, suggestive of activated translocation through
molecular-sized nanopores. A fifth membrane exhibited no measurable
permeance of any gas above the detection limit of our technique, 2
× 10<sup>–7</sup> mol m<sup>–2</sup> s<sup>–1</sup> Pa<sup>–1</sup>, indicating essentially a molecularly impermeable
barrier. Overall, these data demonstrate that SLG membranes can potentially
provide a high mixture separation selectivity for gases, with CVD
synthesis alone resulting in nanometer-scale pores useful for gas
separation. This work also shows that temperature-dependent permeance
measurements on SLG can be used to reveal underlying permeation mechanisms
Controlling Multicycle Replication of Live-Attenuated HIV‑1 Using an Unnatural Genetic Switch
A safe and effective human immunodeficiency
virus type 1 (HIV-1)
vaccine is urgently needed, but remains elusive. While HIV-1 live-attenuated
vaccine can provide potent protection as demonstrated in rhesus macaque-simian
immunodeficiency virus model, the potential pathogenic consequences
associated with the uncontrolled virus replication preclude such vaccine
from clinical applications. We investigated a novel approach to address
this problem by controlling live-attenuated HIV-1 replication through
an unnatural genetic switch that was based on the amber suppression
strategy. Here we report the construction of all-in-one live-attenuated
HIV-1 mutants that contain genomic copy of the amber suppression system.
This genetic modification resulted in viruses that were capable of
multicycle replication <i>in vitro</i> and could be switched
on and off using an unnatural amino acid as the cue. This stand-alone,
replication-controllable attenuated HIV-1 virus represents an important
step toward the generation of a safe and efficacious live-attenuated
HIV-1 vaccine. The strategy reported in this work can be adopted for
the development of other live-attenuated vaccines
A funnel plot of studies conducted on the prevalence of diabetic retinopathy (DR) in mainland China.
<p>A funnel plot of studies conducted on the prevalence of diabetic retinopathy (DR) in mainland China.</p
A forest plot displaying the pooled prevalence of diabetic retinopathy (DR) in the diabetic population of mainland China.
<p>A forest plot displaying the pooled prevalence of diabetic retinopathy (DR) in the diabetic population of mainland China.</p